Inovox Ultra (Flurbiprofen)

Flurbiprofen acts on inflammatory pathways to provide analgesia and reduce swelling in several musculoskeletal conditions.

• Pain relief: Alleviates moderate to severe pain associated with acute and chronic musculoskeletal disorders.
• Osteoarthritis: Improves joint function and lessens pain in degenerative joint disease.
• Rheumatoid arthritis: Decreases inflammatory activity and joint discomfort in autoimmune arthritis.
• Inflammation reduction: Lowers systemic inflammatory markers in conditions requiring NSAID therapy.

• Flurbiprofen reversibly inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, blocking the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis reduces inflammation, pain perception, and fever, providing therapeutic effects in inflammatory and nociceptive conditions.

Flurbiprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Mild skin rash or pruritus.
• Elevated liver enzymes without clinical symptoms.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding.
• Cardiovascular events such as myocardial infarction or stroke.
• Acute renal failure or worsening of chronic kidney disease.
• Severe skin reactions including Stevens‑Johnson syndrome.
• Hepatic failure or severe transaminase elevation.
• Anaphylaxis or other life‑threatening allergic reactions.

When prescribing Flurbiprofen, clinicians should consider several safety measures.

• Assess gastrointestinal risk: review history of ulcers or bleeding before initiating therapy.
• Monitor renal function: adjust use in patients with impaired kidney function.
• Avoid in known NSAID hypersensitivity: discontinue if allergic reactions occur.
• Use lowest effective dose: limit duration to the shortest period necessary.
• Pregnancy and lactation: contraindicated unless benefits clearly outweigh risks.
• Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Flurbiprofen can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• Corticosteroids: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
• Diuretics: may impair renal clearance.
• Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.